Hematology and Oncology
Home Hematology and Oncology
Genetic Testing May Help ID VTE Risk in Breast Cancer Patients
Older breast cancer patients with increased genetic susceptibility receiving chemo have highest risk
October 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2016. This roundup includes...
Use of Term ‘Rule Out’ May Delay Dermatopathology Diagnosis
Use on requisition form linked to longer time to diagnosis, increased use of pathology stains, sections
Initiation, Adherence to AIs Low for Older Women With DCIS
About 45 percent of women initiated treatment with tamoxifen or aromatase inhibitors within one year
Few Changes in Employer-Sponsored Insurance 2013-2014
Only 3.5 percent of employers dropped coverage and 1.1 percent added coverage from 2013 to 2014
Older, Younger Women Equally Benefit From Breast Recon
No greater risk of complications for older patients; benefited as much as younger breast cancer patients
Useful Tips Offered for Addressing Negative Patient Reviews
Doctors should respond quickly, validate patient complaints, demonstrate willingness to take action
Whites Have Longest Survival in Cutaneous Melanoma
For stages I and III, black patients have significantly lower survival, increased hazard ratios
Mohs Effective for Melanoma in Situ of Trunk, Extremities
Surgical margin of 9 mm needed to excise 97 percent of melanoma in situ
Cancer Survivors Have Higher Rate of Antidepressant Use
Nearly one in five survivors taking medication for depression or anxiety years later
